Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25 mg/5 mg/1000 mg Extended- Release Tablets

Triple hormone drug retatrutide shows promise for diabetes and weight loss in Lancet trial

A new triple hormone drug called retatrutide, which mimics GLP-1, GIP, and glucagon, has shown promising results in a Lancet-published trial

New weight loss pill beats oral Ozempic in major trial

FDA Approves Foundayo (orforglipron): The First Oral GLP-1 Weight Loss Pill Without Fasting Requirements

The FDA approved Foundayo (orforglipron), a new once-daily oral GLP-1 weight loss pill by Eli Lilly, on April 1, 2026. Unlike other oral GLP

Farxiga Affordability Tips: From Discount Cards to Patient Assistance

NHS rolls out teplizumab immunotherapy to delay type 1 diabetes onset by three years

The NHS is rolling out teplizumab, an immunotherapy drug that delays the onset of type 1 diabetes by an average of three years in children a

Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us